Sign in
Taking people in United StatesPhase 1

OMAR Opioid Use Disorder

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1
People taking part
30 people, planned
Started
10 Mar 2023
Expected to end
15 Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • [11C]OMAR
Record updated
10 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Able to provide informed consent
  • Male and female 18 years and older
  • DSM-5 diagnosis of opioid use disorder (for OUD group)
  • Physically healthy i.e., no clinically unstable medical conditions
  • Written informed consent and have capacity to consent and comply with study procedures

Who cannot take part

  • Have had exposure to ionizing radiation that in combination with the study tracer would result in a cumulative exposure that exceeds recommended exposure limits
  • Current neuro-psychiatric illness or severe systemic disease (opioid use disorder is permitted in the OUD group)
  • Presence of ferromagnetic metal in the body or heart pacemaker
  • Are claustrophobic
  • Hematocrit values lower than 30

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Opioid use disorder

This trial is currently available in United States.

  • Connecticut Mental Health Center, Clinical Neuroscience Research UnitNew Haven, United StatesContact: Abby DeweyTaking people

About the trial

What the trial wants to find out

The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.

The 2 groups in the trial

  • Healthy VolunteersOther group

    Healthy volunteers with no current or past major medical or psychiatric history

    Treatment: [11C]OMAR

  • Opioid Use DisorderOther group

    Patients diagnosed with opioid use disorder

    Treatment: [11C]OMAR

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Criteria questions
Built from NCT05683184, who can take part
Record updated
10 September 2026